Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Shares Outstanding (2019 - 2022)

Historic Shares Outstanding for Avidity Biosciences (RNA) over the last 4 years, with Q3 2022 value amounting to $54.4 million.

  • Avidity Biosciences' Shares Outstanding rose 1609.7% to $54.4 million in Q3 2022 from the same period last year, while for Sep 2022 it was $54.4 million, marking a year-over-year increase of 1609.7%. This contributed to the annual value of $47.8 million for FY2021, which is 2711.01% up from last year.
  • As of Q3 2022, Avidity Biosciences' Shares Outstanding stood at $54.4 million, which was up 1609.7% from $52.1 million recorded in Q2 2022.
  • Over the past 5 years, Avidity Biosciences' Shares Outstanding peaked at $54.4 million during Q3 2022, and registered a low of $2.9 million during Q2 2019.
  • Its 4-year average for Shares Outstanding is $32.2 million, with a median of $37.6 million in 2020.
  • In the last 5 years, Avidity Biosciences' Shares Outstanding skyrocketed by 118209.77% in 2020 and then soared by 36.77% in 2021.
  • Over the past 4 years, Avidity Biosciences' Shares Outstanding (Quarter) stood at $3.0 million in 2019, then soared by 1156.91% to $37.6 million in 2020, then rose by 27.11% to $47.8 million in 2021, then grew by 14.01% to $54.4 million in 2022.
  • Its Shares Outstanding was $54.4 million in Q3 2022, compared to $52.1 million in Q2 2022 and $49.3 million in Q1 2022.